Bioassays for TSH Receptor Antibodies: Quo Vadis?
作者信息
Kahaly George J
机构信息
Johannes Gutenberg University Medical Center, Mainz, Germany.
出版信息
Eur Thyroid J. 2015 Mar;4(1):3-5. doi: 10.1159/000375445.
Abstract
摘要
相似文献
1
Bioassays for TSH Receptor Antibodies: Quo Vadis?促甲状腺激素受体抗体的生物测定：何去何从？
Eur Thyroid J. 2015 Mar;4(1):3-5. doi: 10.1159/000375445.
2
Quo vadis radioimmune imaging?放射免疫成像何去何从？
J Nucl Med. 1990 Aug;31(8):1439-42.
3
Quo vadis radioimmune imaging.
J Nucl Med. 1989 Nov;30(11):1911-5.
4
Endothelial (DYS)Function: Quo vadis, Cur vadis.内皮（功能障碍）功能：向何处去，因何而去。
J Hypertens. 2012 Jul;30(7):1321-4. doi: 10.1097/HJH.0b013e32835522e2.
5
Meningioma research-status quo and quo vadis.脑膜瘤研究现状与未来走向
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S1. doi: 10.21037/cco.2017.06.21.
6
Radioimmunoimaging. Quo vadis? Toward the imaging of tumor.
J Nucl Med. 1990 Aug;31(8):1436-8.
7
Quo venis quo vadis: the evolution of arthroscopy.你来何处，去往何方：关节镜检查的发展历程
Arthroscopy. 1999 Sep;15(6):680-5. doi: 10.1016/s0749-8063(99)00141-3.
8
Drug receptor assays: quo vadis?
Ann Clin Biochem. 1992 Mar;29 ( Pt 2):132-6. doi: 10.1177/000456329202900202.
9
TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.促甲状腺激素受体自身抗体——格雷夫斯病与毒性多结节性甲状腺肿所致甲状腺功能亢进的鉴别
Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. doi: 10.1055/s-2004-817930.
10
Bioassays for TSH-receptor autoantibodies: an update.促甲状腺激素受体自身抗体的生物测定法：更新。
Autoimmun Rev. 2010 Dec;10(2):116-22. doi: 10.1016/j.autrev.2010.08.018. Epub 2010 Aug 31.
引用本文的文献
1
Artificial intelligence-based CT-free quantitative thyroid SPECT for thyrotoxicosis: study protocol of a multicentre, prospective, non-inferiority study.基于人工智能的 CT -Free 甲状腺 SPECT 定量在甲状腺功能亢进症中的应用：一项多中心、前瞻性、非劣效性研究方案。
BMJ Open. 2024 Oct 14;14(10):e089552. doi: 10.1136/bmjopen-2024-089552.
2
Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.一种自动化 TSI 桥联免疫测定在 Graves 病诊断中的临床评估及其与甲状腺功能亢进程度的关系。
BMC Endocr Disord. 2022 Aug 31;22(1):218. doi: 10.1186/s12902-022-01114-3.
3
TSH Receptor Antibodies (TRAb) Assay: An Underutilized Test in India.促甲状腺激素受体抗体（TRAb）检测：印度一项未得到充分利用的检测
Indian J Endocrinol Metab. 2022 Jan-Feb;26(1):1-3. doi: 10.4103/2230-8210.343876. Epub 2022 Apr 27.
4
Thyrotropin receptor antibody immunoassays may not be reliable in confirming diagnosis of Painless Thyroiditis.促甲状腺激素受体抗体免疫测定在确诊无痛性甲状腺炎方面可能不可靠。
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):530-534. doi: 10.4183/aeb.2020.530.
5
Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link.1 型糖尿病与自身免疫性甲状腺疾病——遗传关联。
Front Endocrinol (Lausanne). 2021 Mar 10;12:618213. doi: 10.3389/fendo.2021.618213. eCollection 2021.
6
Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial.中度至重度活动性格雷夫斯眼眶病类固醇治疗后生活质量变化的预测因素：一项前瞻性试验
Eur Thyroid J. 2021 Feb;9(6):313-320. doi: 10.1159/000508071. Epub 2020 Jul 2.
7
A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies.一种由功能性促甲状腺激素受体抗体证实的新型长期格雷夫斯病动物模型。
Eur Thyroid J. 2020 Dec;9(Suppl 1):51-58. doi: 10.1159/000508790. Epub 2020 Jul 23.
8
Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves' Disease From Autoimmune Thyroiditis.血清游离三碘甲状腺原氨酸与促甲状腺激素比值：鉴别格雷夫斯病与自身免疫性甲状腺炎的新指标。
Front Endocrinol (Lausanne). 2021 Jan 8;11:620407. doi: 10.3389/fendo.2020.620407. eCollection 2020.
9
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.格雷夫斯甲状腺和甲状腺外疾病的管理：更新。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646.
10
Assessment of thyroid function tests and harmonization: opinion on thyroid hormone harmonization.甲状腺功能检查与标准化评估：关于甲状腺激素标准化的意见
Ther Adv Endocrinol Metab. 2019 Dec 24;10:2042018819897049. doi: 10.1177/2042018819897049. eCollection 2019.
本文引用的文献
1
Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin.使用环磷酸腺苷门控钙通道和水母发光蛋白检测促甲状腺素抗体的快速生物测定法。
Eur Thyroid J. 2015 Mar;4(1):14-9. doi: 10.1159/000371740. Epub 2015 Feb 19.
2
A 2013 European survey of clinical practice patterns in the management of Graves' disease.2013年欧洲关于格雷夫斯病管理的临床实践模式调查。
Clin Endocrinol (Oxf). 2016 Jan;84(1):115-20. doi: 10.1111/cen.12688. Epub 2015 Jan 9.
3
Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies.促甲状腺素受体刺激自身抗体生物测定法的标准化
Thyroid. 2015 Feb;25(2):169-75. doi: 10.1089/thy.2014.0346. Epub 2014 Nov 20.
4
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.小儿格雷夫斯病中促甲状腺素自身抗体的临床意义——一项多中心研究。
J Clin Endocrinol Metab. 2014 May;99(5):1648-55. doi: 10.1210/jc.2013-4026. Epub 2014 Feb 11.
5
Clinical review: Clinical utility of TSH receptor antibodies.临床综述：促甲状腺激素受体抗体的临床应用价值。
J Clin Endocrinol Metab. 2013 Jun;98(6):2247-55. doi: 10.1210/jc.2012-4309. Epub 2013 Mar 28.
6
Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins.甲状腺刺激免疫球蛋白生物测定法的分析性能和临床实用性。
Am J Clin Pathol. 2013 Feb;139(2):192-200. doi: 10.1309/AJCPZUT7CNUEU7OP.
7
Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.促甲状腺激素阻断自身抗体和甲状腺刺激自身抗体：在甲状腺功能减退症和甲状腺功能亢进症之间来回摆动或反之亦然的潜在机制。
Thyroid. 2013 Jan;23(1):14-24. doi: 10.1089/thy.2012.0374.
8
A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.一种 TSHr-LH/CGr 嵌合体，可用于测量格雷夫斯病中的功能性 TSAb。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1106-15. doi: 10.1210/jc.2011-2893. Epub 2012 Apr 10.
9
A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.一种 TSHR-LH/CGR 嵌合体，可测量功能型甲状腺刺激自身抗体（TSAb），可预测 Graves 病患者接受抗甲状腺药物（ATD）治疗后的缓解或复发。
J Clin Endocrinol Metab. 2012 Jul;97(7):E1080-7. doi: 10.1210/jc.2011-2897. Epub 2012 Apr 6.
10
Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.新型嵌合促甲状腺激素受体生物测定法与自动化促甲状腺激素受体结合测定法在 Graves 病中的临床性能相似。
Thyroid. 2011 Dec;21(12):1295-9. doi: 10.1089/thy.2011.0056. Epub 2011 Nov 8.
Zotero 插件